This week, Oregon’s Opioid Settlement Board will decide how to spend millions of dollars recovered from drug companies to mitigate the state’s drug crisis. Last year, the board crafted a balanced ...

Treating high-risk, statin-intolerant patients without a prior cardiovascular event with bempedoic acid (Nexletol; Esperion) leads to a significant reduction in their risk of atherosclerotic ...